,Set,NGenes,Direction,PValue,FDR
1,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,7,Down,0.00121962585119814,0.399350926359226
2,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,86,Up,0.00220049701561475,0.399350926359226
3,WP_ESTROGEN_METABOLISM_WP697,5,Up,0.00237035665404133,0.399350926359226
4,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,10,Down,0.00274804735903977,0.399350926359226
5,WP_IRON_METABOLISM_DISORDERS,10,Up,0.00346167658994978,0.399350926359226
6,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,14,Down,0.00432473371500141,0.399350926359226
7,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,46,Up,0.00585997694778571,0.399350926359226
8,WP_HEDGEHOG_SIGNALING_WP47,6,Up,0.00615869108352211,0.399350926359226
9,WP_INTEGRATED_CANCER_PATHWAY,40,Up,0.00697555798730516,0.399350926359226
10,WP_BENZENE_METABOLISM,3,Up,0.00711122576250048,0.399350926359226
11,WP_DNA_DAMAGE_RESPONSE,58,Up,0.00736190508788594,0.399350926359226
12,WP_ZINC_HOMEOSTASIS,21,Up,0.00780658350569608,0.399350926359226
13,WP_GABA_RECEPTOR_SIGNALING,10,Up,0.00820553388838109,0.399350926359226
14,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,12,Up,0.00838709265493509,0.399350926359226
15,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,50,Up,0.00908000368977054,0.399350926359226
16,WP_VITAMIN_B12_METABOLISM,22,Up,0.00932067705969361,0.399350926359226
17,WP_INFLAMMATORY_RESPONSE_PATHWAY,13,Up,0.00937455097704742,0.399350926359226
18,WP_SMALL_CELL_LUNG_CANCER,68,Up,0.0104167143647896,0.399350926359226
19,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,17,Up,0.0104718651551189,0.399350926359226
20,WP_LIVER_X_RECEPTOR_PATHWAY,5,Up,0.0109709246685524,0.399350926359226
21,WP_FERROPTOSIS,50,Up,0.0110790293250236,0.399350926359226
22,WP_NEPHROGENESIS,4,Down,0.0116292547438621,0.399350926359226
23,WP_SULFATASE_AND_AROMATASE_PATHWAY,2,Up,0.0121815941271654,0.399350926359226
24,WP_OXIDATIVE_STRESS_RESPONSE,21,Up,0.012358789016617,0.399350926359226
25,WP_FATTY_ACID_TRANSPORTERS,10,Up,0.0124447040954753,0.399350926359226
26,WP_GDNFRET_SIGNALING_AXIS,4,Up,0.0126315378167152,0.399350926359226
27,WP_DOPAMINE_METABOLISM,7,Up,0.0131418147503052,0.400095249064846
28,WP_IRON_METABOLISM_IN_PLACENTA,8,Up,0.0144977886114117,0.425613651377873
29,WP_OXIDATIVE_PHOSPHORYLATION,50,Up,0.015602071185454,0.44223801773942
30,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,5,Down,0.0162938729391748,0.446452118533389
31,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,20,Up,0.0186557034679029,0.494677040342458
32,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,19,Up,0.0198974003267409,0.499372847721318
33,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,59,Up,0.0200478150545055,0.499372847721318
34,WP_COMPLEMENT_ACTIVATION,12,Up,0.0221304751356002,0.523449933557836
35,WP_GENES_CONTROLLING_NEPHROGENESIS,13,Up,0.0222880142025843,0.523449933557836
36,WP_SELENIUM_MICRONUTRIENT_NETWORK,48,Up,0.0246177833062286,0.530927026971317
37,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,39,Down,0.0246451527815993,0.530927026971317
38,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,2,Down,0.0247179273525423,0.530927026971317
39,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,16,Down,0.0251899684329457,0.530927026971317
40,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,128,Up,0.0265244236996018,0.539170231325514
41,WP_LEPTININSULIN_SIGNALING_OVERLAP,13,Up,0.0272893434146071,0.539170231325514
42,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,17,Down,0.0275488439363401,0.539170231325514
43,WP_RETINOBLASTOMA_GENE_IN_CANCER,68,Up,0.0285870846184997,0.546478687358297
44,WP_GPCRS_OTHER,10,Down,0.0305819281375915,0.571326021115914
45,WP_OXIDATIVE_DAMAGE_RESPONSE,32,Up,0.0323622033602145,0.591149581379919
46,WP_FOLATE_METABOLISM,35,Up,0.0344664914891134,0.598383724206544
47,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,4,Up,0.0357668155877563,0.598383724206544
48,WP_BREAST_CANCER_PATHWAY,87,Up,0.0372050669112749,0.598383724206544
49,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,9,Down,0.0380185620003784,0.598383724206544
50,WP_MONOAMINE_GPCRS,3,Down,0.0391399295175807,0.598383724206544
51,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,9,Up,0.0399543802414739,0.598383724206544
52,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,73,Up,0.0421424381234637,0.598383724206544
53,WP_NRF2_PATHWAY,71,Up,0.0426707389458563,0.598383724206544
54,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,21,Up,0.0428838995872916,0.598383724206544
55,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,13,Down,0.0430176990921352,0.598383724206544
56,WP_ENERGY_METABOLISM,41,Down,0.0436676861294804,0.598383724206544
57,WP_ALLOGRAFT_REJECTION,50,Up,0.0442809541837805,0.598383724206544
58,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,5,Up,0.0442940004719782,0.598383724206544
59,WP_IDO_METABOLIC_PATHWAY,7,Down,0.044449253144396,0.598383724206544
60,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,14,Down,0.0449421024215377,0.598383724206544
61,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,10,Down,0.0460127651610024,0.598383724206544
62,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,15,Up,0.0464006863060261,0.598383724206544
63,WP_ANGIOGENESIS,13,Up,0.0465557208748913,0.598383724206544
64,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,5,Down,0.0471906263775055,0.598383724206544
65,WP_PEPTIDE_GPCRS,13,Down,0.0473174477778897,0.598383724206544
66,WP_PPARALPHA_PATHWAY,15,Up,0.0511120084627667,0.63657683267264
67,WP_COPPER_HOMEOSTASIS,39,Up,0.0542069930734558,0.665046989647473
68,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,71,Up,0.0556739287127757,0.668840949947611
69,WP_CHOLESTASIS,9,Up,0.0563100578481171,0.668840949947611
70,WP_DISORDERS_OF_GALACTOSE_METABOLISM,9,Down,0.0572921078746239,0.668840949947611
71,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,4,Up,0.0579716546385622,0.668840949947611
72,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,32,Down,0.0586692311818061,0.668840949947611
73,WP_FTO_OBESITY_VARIANT_MECHANISM,2,Up,0.0599759737212585,0.668840949947611
74,WP_BENZOAPYRENE_METABOLISM,5,Up,0.0610047114871093,0.668840949947611
75,WP_RANKLRANK_SIGNALING,47,Up,0.0610256341193076,0.668840949947611
76,WP_PDGF_PATHWAY,36,Down,0.0644377269935967,0.680727098474425
77,WP_NUCLEOTIDE_GPCRS,5,Down,0.0651977353326386,0.680727098474425
78,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,10,Up,0.0656396669511737,0.680727098474425
79,WP_RETINOL_METABOLISM,6,Down,0.0670302813226493,0.680727098474425
80,WP_IL7_SIGNALING,23,Up,0.06747963110092,0.680727098474425
81,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,45,Up,0.067807046178725,0.680727098474425
82,WP_THERMOGENESIS,74,Down,0.0679070828161835,0.680727098474425
83,WP_HUNGER_AND_SATIETY,2,Down,0.0707648508058593,0.700827799547185
84,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,85,Up,0.0769471505868491,0.740662711706264
85,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,18,Up,0.0770868136297166,0.740662711706264
86,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,21,Up,0.0774902593755945,0.740662711706264
87,WP_IL26_SIGNALING,31,Up,0.0792436204463016,0.742202851933536
88,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,10,Down,0.0794572396230549,0.742202851933536
89,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,1,Down,0.0820084462376894,0.757426323678435
90,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,12,Down,0.0841194397594032,0.76001847330322
91,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,15,Down,0.0844102580463152,0.76001847330322
92,WP_OSTEOCLAST_SIGNALING,9,Up,0.0859706011437314,0.76001847330322
93,WP_SPINAL_CORD_INJURY,64,Up,0.0860700852609892,0.76001847330322
94,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,4,Down,0.0872824516575053,0.76001847330322
95,WP_CODEINE_AND_MORPHINE_METABOLISM,1,Up,0.0885856897902585,0.76001847330322
96,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,3,Down,0.0895292849202227,0.76001847330322
97,WP_MELANOMA,53,Up,0.0900215736988283,0.76001847330322
98,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,2,Down,0.090610474919362,0.76001847330322
99,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,17,Down,0.0922810537279015,0.766212385498334
100,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,17,Up,0.0937341627454611,0.77049481776769
101,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,2,Up,0.0957744903602916,0.771610971785505
102,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,11,Up,0.0965509136442366,0.771610971785505
103,WP_CCL18_SIGNALING,20,Up,0.0973496374951853,0.771610971785505
104,WP_GPCRS_CLASS_A_RHODOPSINLIKE,40,Down,0.0984286971193202,0.771610971785505
105,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,50,Up,0.0985634453010682,0.771610971785505
106,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,22,Down,0.101163003134943,0.775028201208827
107,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,7,Up,0.101727149290342,0.775028201208827
108,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,5,Up,0.101828522786561,0.775028201208827
109,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,8,Up,0.103539075154901,0.78081761263604
110,WP_P38_MAPK_SIGNALING,31,Down,0.106503892543928,0.795874542464626
111,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,17,Down,0.108886193590694,0.801474512507985
112,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,30,Up,0.109389437961626,0.801474512507985
113,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,6,Up,0.110178369724334,0.801474512507985
114,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,6,Down,0.114338228093719,0.816621060853247
115,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,14,Up,0.114867564295046,0.816621060853247
116,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,29,Up,0.115596387534019,0.816621060853247
117,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,12,Up,0.119940190007977,0.816621060853247
118,WP_4P163_COPY_NUMBER_VARIATION,21,Down,0.120267152043188,0.816621060853247
119,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,26,Up,0.121248000121656,0.816621060853247
120,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,10,Up,0.121277251325899,0.816621060853247
121,WP_G13_SIGNALING,29,Down,0.122946984895368,0.816621060853247
122,WP_GLYCOSPHINGOLIPID_METABOLISM,12,Down,0.124522060511111,0.816621060853247
123,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,37,Down,0.127772285163748,0.816621060853247
124,WP_ATR_SIGNALING,10,Up,0.129033492108587,0.816621060853247
125,WP_TRIACYLGLYCERIDE_SYNTHESIS,18,Down,0.129108867029686,0.816621060853247
126,WP_SILDENAFIL_TREATMENT,10,Up,0.134019523462387,0.816621060853247
127,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,131,Up,0.134300605661301,0.816621060853247
128,WP_TROP2_REGULATORY_SIGNALING,42,Up,0.134888417730705,0.816621060853247
129,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,4,Up,0.135876383484062,0.816621060853247
130,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,8,Down,0.13590035925,0.816621060853247
131,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,24,Down,0.136061200656199,0.816621060853247
132,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,9,Down,0.136098668997959,0.816621060853247
133,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,5,Up,0.13628198207217,0.816621060853247
134,WP_TP53_NETWORK,16,Up,0.139295730609793,0.816621060853247
135,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,7,Up,0.139353765424692,0.816621060853247
136,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,17,Up,0.140928590314512,0.816621060853247
137,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,11,Down,0.141344694926584,0.816621060853247
138,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,19,Down,0.141882686959426,0.816621060853247
139,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,42,Down,0.144160535229509,0.816621060853247
140,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,15,Down,0.144361503630931,0.816621060853247
141,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,2,Up,0.145119961747389,0.816621060853247
142,WP_IRONSULFUR_CLUSTER_BIOGENESIS,15,Down,0.145785254264873,0.816621060853247
143,WP_TGFB_SMAD_SIGNALING,7,Down,0.146894386702337,0.816621060853247
144,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,61,Up,0.148963180559376,0.816621060853247
145,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,3,Up,0.149080318005076,0.816621060853247
146,WP_NUCLEAR_RECEPTORS_METAPATHWAY,175,Up,0.149258817722246,0.816621060853247
147,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,23,Up,0.149523355135069,0.816621060853247
148,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,76,Down,0.149667630936368,0.816621060853247
149,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,8,Up,0.149767274806091,0.816621060853247
150,WP_HEME_BIOSYNTHESIS,8,Up,0.149767274806091,0.816621060853247
151,WP_UROTENSINIIMEDIATED_SIGNALING,48,Up,0.150011898039952,0.816621060853247
152,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,32,Up,0.151353311249397,0.818502775309241
153,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,2,Down,0.152810771923977,0.819031284384929
154,WP_CELL_DIFFERENTIATION_INDEX,7,Down,0.153835301789377,0.819031284384929
155,WP_15Q11Q13_COPY_NUMBER_VARIATION,33,Up,0.155348609404896,0.819031284384929
156,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,19,Up,0.156431663537918,0.819031284384929
157,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,9,Down,0.156432982540674,0.819031284384929
158,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,46,Down,0.159081575085888,0.821738338956011
159,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,40,Up,0.159264354799033,0.821738338956011
160,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,12,Up,0.16095506321823,0.821738338956011
161,WP_TAMOXIFEN_METABOLISM,2,Up,0.161817872444819,0.821738338956011
162,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,9,Up,0.162227153025979,0.821738338956011
163,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,10,Up,0.163277302590976,0.821738338956011
164,WP_GASTRIC_CANCER_NETWORK_2,24,Up,0.164498301883105,0.821738338956011
165,WP_BLOOD_CLOTTING_CASCADE,5,Down,0.16582939462784,0.821738338956011
166,WP_KALLMANN_SYNDROME,11,Up,0.165954963247427,0.821738338956011
167,WP_NEURAL_CREST_DIFFERENTIATION,39,Up,0.166946840152864,0.821738338956011
168,WP_TOLLLIKE_RECEPTOR_SIGNALING,79,Up,0.168567860642274,0.8247784609997
169,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,28,Down,0.170026860815796,0.82699455379044
170,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,12,Down,0.175094618660591,0.846395204370307
171,WP_HIPPOYAP_SIGNALING,16,Up,0.176314798912123,0.846395204370307
172,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,73,Up,0.177104592641962,0.846395204370307
173,WP_CANCER_PATHWAYS,302,Up,0.181774261905876,0.85249242243282
174,WP_G1_TO_S_CELL_CYCLE_CONTROL,50,Up,0.182111084867381,0.85249242243282
175,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,27,Down,0.182580508790628,0.85249242243282
176,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,2,Up,0.182877597052756,0.85249242243282
177,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,3,Up,0.185563327979518,0.85249242243282
178,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,15,Down,0.186281465690743,0.85249242243282
179,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,60,Up,0.18822349990182,0.85249242243282
180,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,6,Up,0.188636698352208,0.85249242243282
181,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,17,Up,0.189078871296343,0.85249242243282
182,WP_VITAMIN_B12_DISORDERS,9,Down,0.190023239328191,0.85249242243282
183,WP_IL18_SIGNALING,186,Up,0.190626920043991,0.85249242243282
184,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,3,Up,0.192548029002668,0.85249242243282
185,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,10,Up,0.193035016623717,0.85249242243282
186,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,1,Down,0.193099359830287,0.85249242243282
187,WP_NGLYCAN_BIOSYNTHESIS,52,Down,0.193936840626444,0.85249242243282
188,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,13,Down,0.195591797711402,0.855193924036022
189,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,2,Up,0.197152572116228,0.85745721841026
190,WP_ESTROGEN_RECEPTOR_PATHWAY,8,Up,0.205146220125415,0.882216153848743
191,WP_MALE_INFERTILITY,66,Up,0.205694299579609,0.882216153848743
192,WP_PROSTAGLANDIN_SIGNALING,19,Down,0.206065087030363,0.882216153848743
193,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,33,Down,0.207901543014247,0.883576717522208
194,WP_ONECARBON_METABOLISM,22,Up,0.20853270462203,0.883576717522208
195,WP_ARYLAMINE_METABOLISM,1,Up,0.212316370708551,0.890401974345204
196,WP_PANCREATIC_CANCER_SUBTYPES,5,Down,0.213112219613738,0.890401974345204
197,WP_ACETYLCHOLINE_SYNTHESIS,4,Down,0.214898842862514,0.890401974345204
198,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,25,Up,0.215481696051776,0.890401974345204
199,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,7,Up,0.216794085743171,0.890401974345204
200,WP_POSTCOVID_NEUROINFLAMMATION,11,Down,0.217605648521138,0.890401974345204
201,WP_PROTEASOME_DEGRADATION,57,Up,0.218981769437805,0.890401974345204
202,WP_GLUCOCORTICOID_BIOSYNTHESIS,6,Up,0.219817103747412,0.890401974345204
203,WP_10Q22Q23_COPY_NUMBER_VARIATION,27,Down,0.220638084260844,0.890401974345204
204,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,8,Up,0.221067259437531,0.890401974345204
205,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,11,Up,0.224195012114121,0.890401974345204
206,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,170,Up,0.225701205534229,0.890401974345204
207,WP_ENDOMETRIAL_CANCER,49,Up,0.22616920594415,0.890401974345204
208,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,6,Up,0.228389606985013,0.890401974345204
209,WP_APOPTOSIS_MODULATION_AND_SIGNALING,78,Up,0.229018067511753,0.890401974345204
210,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,3,Up,0.229425767881095,0.890401974345204
211,WP_APOPTOSIS,71,Up,0.230890933807851,0.890401974345204
212,WP_FOXP3_IN_COVID19,9,Up,0.233088684616891,0.890401974345204
213,WP_DISORDERS_IN_KETOLYSIS,4,Down,0.233654029934108,0.890401974345204
214,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,65,Up,0.235808213196219,0.890401974345204
215,WP_GLUTATHIONE_METABOLISM,10,Up,0.235960060280767,0.890401974345204
216,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,8,Up,0.236262742447863,0.890401974345204
217,WP_PYRIMIDINE_METABOLISM,71,Up,0.236927594862464,0.890401974345204
218,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,7,Down,0.237519794321474,0.890401974345204
219,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,11,Down,0.238585144944431,0.890401974345204
220,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,16,Up,0.23860261402789,0.890401974345204
221,WP_MINERALOCORTICOID_BIOSYNTHESIS,5,Up,0.239713621652358,0.890401974345204
222,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,2,Down,0.240633011958435,0.890401974345204
223,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,29,Up,0.243274283645076,0.890401974345204
224,WP_LUNG_FIBROSIS,32,Down,0.2444966870158,0.890401974345204
225,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1,Up,0.24556285158062,0.890401974345204
226,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,14,Down,0.245806798135307,0.890401974345204
227,WP_PROLACTIN_SIGNALING,69,Up,0.245889596321607,0.890401974345204
228,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,11,Down,0.247472016242489,0.892201742768973
229,WP_CIRCADIAN_RHYTHM_GENES,119,Up,0.252657873830307,0.89550188694941
230,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,9,Up,0.255103590995019,0.89550188694941
231,WP_NRF2ARE_REGULATION,20,Up,0.255127266980012,0.89550188694941
232,WP_PTF1A_RELATED_REGULATORY_PATHWAY,6,Up,0.255383999577427,0.89550188694941
233,WP_RETT_SYNDROME,31,Down,0.256434196447457,0.89550188694941
234,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,10,Down,0.25697555112707,0.89550188694941
235,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,35,Up,0.258019694357946,0.89550188694941
236,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,19,Down,0.259637926445021,0.89550188694941
237,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,60,Up,0.261376187413544,0.89550188694941
238,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,8,Down,0.261589852304371,0.89550188694941
239,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,15,Up,0.265482798681645,0.89550188694941
240,WP_SPHINGOLIPID_PATHWAY,19,Down,0.266161445165388,0.89550188694941
241,WP_SMALL_LIGAND_GPCRS,7,Up,0.267429229742112,0.89550188694941
242,WP_AUTOPHAGY,27,Down,0.26784955592291,0.89550188694941
243,WP_KREBS_CYCLE_DISORDERS,11,Down,0.268247544963379,0.89550188694941
244,WP_EBOLA_VIRUS_INFECTION_IN_HOST,105,Up,0.268765821469814,0.89550188694941
245,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,28,Down,0.269619931448068,0.89550188694941
246,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,19,Up,0.270149004366386,0.89550188694941
247,WP_ID_SIGNALING,12,Up,0.270574979776383,0.89550188694941
248,WP_PILOCYTIC_ASTROCYTOMA,6,Down,0.272300230157364,0.89550188694941
249,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,13,Up,0.272635804079467,0.89550188694941
250,WP_CELL_CYCLE,92,Up,0.273397444735509,0.89550188694941
251,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,9,Up,0.274768459988403,0.89550188694941
252,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,36,Up,0.275032143292509,0.89550188694941
253,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,43,Up,0.275622843550123,0.89550188694941
254,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,19,Down,0.277914794056624,0.896255922134021
255,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,37,Up,0.278035596282452,0.896255922134021
256,WP_WNT_SIGNALING_WP428,58,Up,0.280866693070308,0.898026759321799
257,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,31,Up,0.281924014026049,0.898026759321799
258,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,15,Up,0.282830158886508,0.898026759321799
259,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,19,Up,0.28402856991997,0.898026759321799
260,WP_CREATINE_PATHWAY,2,Down,0.285170841295288,0.898026759321799
261,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,1,Down,0.286167725190783,0.898026759321799
262,WP_NONSMALL_CELL_LUNG_CANCER,58,Up,0.286852307710185,0.898026759321799
263,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,57,Down,0.287531428708195,0.898026759321799
264,WP_MESODERMAL_COMMITMENT_PATHWAY,76,Up,0.289526335804746,0.898026759321799
265,WP_PREIMPLANTATION_EMBRYO,21,Up,0.291275996045947,0.898026759321799
266,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,13,Up,0.29182602402161,0.898026759321799
267,WP_PI3KAKT_SIGNALING,176,Up,0.292570498748286,0.898026759321799
268,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,40,Up,0.294108146119855,0.898026759321799
269,WP_PRION_DISEASE_PATHWAY,28,Up,0.294880097085937,0.898026759321799
270,WP_PPAR_SIGNALING,39,Up,0.295566186060024,0.898026759321799
271,WP_SYNAPTIC_VESICLE_PATHWAY,21,Up,0.296503177953986,0.898026759321799
272,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,9,Up,0.297157273157578,0.898026759321799
273,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,5,Up,0.300831170944958,0.902784511998234
274,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,20,Up,0.300928170666078,0.902784511998234
275,WP_NOTCH_SIGNALING_WP61,49,Up,0.302830183919008,0.903508338774563
276,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,39,Up,0.30336776338416,0.903508338774563
277,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,7,Up,0.305405506037471,0.906293595533579
278,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,18,Down,0.307592944618204,0.907322758170997
279,WP_TYPE_II_INTERFERON_SIGNALING,30,Up,0.308224278095898,0.907322758170997
280,WP_MITOCHONDRIAL_GENE_EXPRESSION,16,Down,0.309779286068946,0.907322758170997
281,WP_CARDIAC_HYPERTROPHIC_RESPONSE,44,Up,0.310167512221472,0.907322758170997
282,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,12,Down,0.313271399431325,0.910363334659824
283,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,86,Up,0.315319796705007,0.910363334659824
284,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,12,Down,0.317720492952981,0.910363334659824
285,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,15,Up,0.317745374482736,0.910363334659824
286,WP_PURINERGIC_SIGNALING,14,Down,0.317854739503024,0.910363334659824
287,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,56,Up,0.320491045350755,0.910363334659824
288,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,86,Up,0.321873665116725,0.910363334659824
289,WP_FARNESOID_X_RECEPTOR_PATHWAY,5,Up,0.323021518038564,0.910363334659824
290,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,21,Up,0.324829413177934,0.910363334659824
291,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,22,Up,0.324870378822996,0.910363334659824
292,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,63,Down,0.327702361495403,0.910363334659824
293,WP_VALPROIC_ACID_PATHWAY,9,Down,0.328203978940087,0.910363334659824
294,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,31,Down,0.329555412981015,0.910363334659824
295,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,13,Up,0.329638736111957,0.910363334659824
296,WP_PROXIMAL_TUBULE_TRANSPORT,25,Down,0.329730074862952,0.910363334659824
297,WP_BURN_WOUND_HEALING,57,Up,0.331683199404361,0.910363334659824
298,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,33,Up,0.331973621483726,0.910363334659824
299,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,26,Up,0.332206480128769,0.910363334659824
300,WP_ESTROGEN_SIGNALING,21,Up,0.332249392211615,0.910363334659824
301,WP_GASTRIC_CANCER_NETWORK_1,16,Up,0.335052777969629,0.914994629538322
302,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,7,Down,0.337898761612388,0.91629362871797
303,WP_GABA_METABOLISM_AKA_GHB,4,Down,0.338503624774189,0.91629362871797
304,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,32,Up,0.338872582883532,0.91629362871797
305,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,24,Up,0.340630495255109,0.918027105244917
306,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,21,Up,0.344106361748158,0.924364148225445
307,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,20,Down,0.348607521543629,0.926267101093711
308,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,20,Up,0.349366841422523,0.926267101093711
309,WP_IL3_SIGNALING,46,Down,0.349560139725888,0.926267101093711
310,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,51,Up,0.349974419410354,0.926267101093711
311,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,8,Up,0.350448988370005,0.926267101093711
312,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,2,Down,0.353509002403451,0.927554887458558
313,WP_ENDODERM_DIFFERENTIATION,81,Up,0.354255835510731,0.927554887458558
314,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,18,Up,0.354321453360082,0.927554887458558
315,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,9,Up,0.359294758741123,0.933691652863261
316,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,14,Down,0.359944423763329,0.933691652863261
317,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,9,Up,0.360965589386404,0.933691652863261
318,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,16,Up,0.36196119697916,0.933691652863261
319,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,47,Up,0.364694043324633,0.933691652863261
320,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,14,Down,0.365767974740892,0.933691652863261
321,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,18,Down,0.366378137130715,0.933691652863261
322,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.367239330024633,0.933691652863261
323,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,8,Down,0.367560826124917,0.933691652863261
324,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,37,Up,0.368360179692201,0.933691652863261
325,WP_FLUOROPYRIMIDINE_ACTIVITY,25,Up,0.371102755797596,0.933691652863261
326,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,13,Up,0.371137115283889,0.933691652863261
327,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,11,Up,0.37258564087456,0.933691652863261
328,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,12,Down,0.373635945552818,0.933691652863261
329,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,7,Up,0.373703836729943,0.933691652863261
330,WP_15Q25_COPY_NUMBER_VARIATION,28,Down,0.375676480874111,0.935775961450057
331,WP_IL9_SIGNALING,15,Up,0.376986763516164,0.935838495130249
332,WP_INTERFERONMEDIATED_SIGNALING,15,Up,0.377978564943118,0.935838495130249
333,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,14,Down,0.380663664419548,0.939656252711317
334,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,27,Down,0.384060688086431,0.94394210115745
335,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,22,Up,0.384696598403584,0.94394210115745
336,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,3,Up,0.387743457924037,0.948586673849875
337,WP_GLIAL_CELL_DIFFERENTIATION,4,Down,0.389748335215021,0.950662111414679
338,WP_EICOSANOID_SYNTHESIS,13,Down,0.39390159182988,0.954748794066866
339,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,6,Down,0.394087629227027,0.954748794066866
340,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,55,Up,0.394908260319628,0.954748794066866
341,WP_ASPIRIN_AND_MIRNAS,8,Down,0.398268004451389,0.95758523747479
342,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,7,Down,0.398444396687737,0.95758523747479
343,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,70,Down,0.400536353038285,0.95758523747479
344,WP_VITAMIN_D_METABOLISM,6,Down,0.401326497890051,0.95758523747479
345,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,38,Up,0.402949822035188,0.95758523747479
346,WP_LEUKOTRIENE_METABOLIC_PATHWAY,8,Down,0.403807013869857,0.95758523747479
347,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,46,Down,0.405055104594489,0.95758523747479
348,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,21,Down,0.406275251244525,0.95758523747479
349,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,14,Up,0.408296111662473,0.95758523747479
350,WP_MEVALONATE_PATHWAY,7,Down,0.408625404468492,0.95758523747479
351,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,6,Up,0.408895886075001,0.95758523747479
352,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,11,Down,0.413388943168368,0.959645796865004
353,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,3,Down,0.417072030979034,0.959645796865004
354,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,5,Up,0.417634046077602,0.959645796865004
355,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,10,Down,0.418714885956736,0.959645796865004
356,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,7,Up,0.419025758378871,0.959645796865004
357,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,28,Down,0.419729521216264,0.959645796865004
358,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,48,Down,0.420254311314515,0.959645796865004
359,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,45,Up,0.420810309346161,0.959645796865004
360,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,102,Down,0.423232642930159,0.959645796865004
361,WP_SULINDAC_METABOLIC_PATHWAY,2,Down,0.423498046910332,0.959645796865004
362,WP_ERBB_SIGNALING,67,Up,0.42374859908812,0.959645796865004
363,WP_NUCLEAR_RECEPTORS,20,Down,0.427610526155372,0.959645796865004
364,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,8,Up,0.427660825225249,0.959645796865004
365,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,51,Up,0.427748532215368,0.959645796865004
366,WP_HOMOLOGOUS_RECOMBINATION,11,Down,0.427859509051709,0.959645796865004
367,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,40,Down,0.429338914159978,0.959645796865004
368,WP_PLEURAL_MESOTHELIOMA,248,Up,0.430832587044198,0.959645796865004
369,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,7,Down,0.431423095861676,0.959645796865004
370,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,8,Down,0.431957353820014,0.959645796865004
371,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,8,Up,0.433282742128293,0.959995725146784
372,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,9,Down,0.437321499823083,0.960344259016323
373,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,4,Down,0.437906589138023,0.960344259016323
374,WP_TAR_SYNDROME,43,Down,0.439115828808921,0.960344259016323
375,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,30,Down,0.439586576055713,0.960344259016323
376,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,3,Up,0.440831621505083,0.960344259016323
377,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,19,Down,0.441393028976309,0.960344259016323
378,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,49,Up,0.441618162905316,0.960344259016323
379,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,43,Up,0.44419115905395,0.96339085156292
380,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,20,Up,0.44625322498377,0.964134488715577
381,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,11,Down,0.44687985425868,0.964134488715577
382,WP_KININKALLIKREIN_PATHWAY,2,Up,0.451207356380919,0.969489059300582
383,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,6,Up,0.452386632035403,0.969489059300582
384,WP_ECTODERM_DIFFERENTIATION,76,Up,0.453247197003588,0.969489059300582
385,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,45,Down,0.455823185714558,0.969489059300582
386,WP_GLYCOSAMINOGLYCAN_DEGRADATION,14,Down,0.456185162371682,0.969489059300582
387,WP_GANGLIO_SPHINGOLIPID_METABOLISM,6,Down,0.456438279743705,0.969489059300582
388,WP_CYTOSINE_METHYLATION,7,Up,0.461297373596932,0.973638576429103
389,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,15,Up,0.462779892582763,0.973638576429103
390,WP_BIOGENIC_AMINE_SYNTHESIS,1,Up,0.463129785138418,0.973638576429103
391,WP_NEUROTRANSMITTER_DISORDERS,1,Up,0.463129785138418,0.973638576429103
392,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,10,Up,0.467557400886857,0.976937096480415
393,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,15,Down,0.470100288454875,0.976937096480415
394,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,113,Up,0.470557119146174,0.976937096480415
395,WP_EPO_RECEPTOR_SIGNALING,23,Up,0.470917137906332,0.976937096480415
396,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,82,Up,0.4712842279919,0.976937096480415
397,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,10,Up,0.472323450620223,0.976937096480415
398,WP_RUBINSTEINTAYBI_SYNDROME_1,12,Down,0.473018204865213,0.976937096480415
399,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,44,Up,0.47428426990796,0.97709691695324
400,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,69,Up,0.475500153998512,0.977109448317944
401,WP_CANONICAL_NFKB_PATHWAY,8,Up,0.480721417373753,0.977109448317944
402,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,40,Down,0.480881705080946,0.977109448317944
403,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,11,Down,0.481588924143474,0.977109448317944
404,WP_NEPHROTIC_SYNDROME,27,Up,0.482578958547163,0.977109448317944
405,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,18,Down,0.485087670410233,0.977109448317944
406,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,13,Down,0.486832491663837,0.977109448317944
407,WP_NEOVASCULARIZATION_PROCESSES,22,Up,0.487715014408586,0.977109448317944
408,WP_FRAGILE_X_SYNDROME,83,Down,0.489068966252985,0.977109448317944
409,WP_IL10_ANTIINFLAMMATORY_SIGNALING,10,Up,0.49026745854394,0.977109448317944
410,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,20,Down,0.497023912449357,0.977109448317944
411,WP_FOXA2_PATHWAY,9,Up,0.498881027798598,0.977109448317944
412,WP_CELLULAR_PROTEOSTASIS,6,Up,0.500570510727021,0.977109448317944
413,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,15,Up,0.501111867009097,0.977109448317944
414,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,12,Up,0.501961971536808,0.977109448317944
415,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,72,Down,0.502250144111407,0.977109448317944
416,WP_MTHFR_DEFICIENCY,18,Up,0.502461021154786,0.977109448317944
417,WP_13Q1212_COPY_NUMBER_VARIATION,20,Down,0.503943929222402,0.977109448317944
418,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,35,Down,0.504243253673963,0.977109448317944
419,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,33,Up,0.505099773871407,0.977109448317944
420,WP_CHEMOKINE_SIGNALING,108,Down,0.505417424379714,0.977109448317944
421,WP_PDGFRBETA_PATHWAY,26,Down,0.511561158233395,0.977109448317944
422,WP_WNT_SIGNALING_AND_PLURIPOTENCY,59,Down,0.512573480231973,0.977109448317944
423,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,11,Down,0.516862259503018,0.977109448317944
424,WP_RALA_DOWNSTREAM_REGULATED_GENES,12,Down,0.517790646326492,0.977109448317944
425,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,13,Up,0.51918307314716,0.977109448317944
426,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,10,Up,0.523159458398468,0.977109448317944
427,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,3,Down,0.523621068233804,0.977109448317944
428,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,16,Down,0.523896293558544,0.977109448317944
429,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,19,Down,0.52417252521983,0.977109448317944
430,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,24,Up,0.524552467638557,0.977109448317944
431,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,22,Up,0.525294595654644,0.977109448317944
432,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,34,Down,0.528662748143505,0.977109448317944
433,WP_PROTEOGLYCAN_BIOSYNTHESIS,15,Down,0.529165680321523,0.977109448317944
434,WP_IL19_SIGNALING,20,Up,0.530478987734313,0.977109448317944
435,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,14,Up,0.532581692950747,0.977109448317944
436,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,15,Up,0.533015811715207,0.977109448317944
437,WP_BASE_EXCISION_REPAIR,29,Up,0.533154286001211,0.977109448317944
438,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,14,Up,0.534784607458195,0.977109448317944
439,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,12,Up,0.535223558007274,0.977109448317944
440,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,19,Up,0.536948923864901,0.977109448317944
441,WP_SULFATION_BIOTRANSFORMATION_REACTION,6,Up,0.537636281869193,0.977109448317944
442,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,13,Up,0.537676008780259,0.977109448317944
443,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,4,Up,0.538121844256537,0.977109448317944
444,WP_PAFAH1B1_COPY_NUMBER_VARIATION,9,Down,0.542620017366542,0.977109448317944
445,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,16,Down,0.543164924556348,0.977109448317944
446,WP_ETHER_LIPID_BIOSYNTHESIS,16,Down,0.543842188178189,0.977109448317944
447,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,15,Down,0.544137527419224,0.977109448317944
448,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,10,Down,0.547594782743586,0.977109448317944
449,WP_GLIOBLASTOMA_SIGNALING,66,Up,0.549713851104486,0.977109448317944
450,WP_NAD_METABOLISM,12,Down,0.549777336746714,0.977109448317944
451,WP_GLUCURONIDATION,7,Down,0.550017718891737,0.977109448317944
452,WP_ALSTROM_SYNDROME,27,Up,0.551437207015848,0.977109448317944
453,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,105,Up,0.552906265150919,0.977109448317944
454,WP_JOUBERT_SYNDROME,71,Down,0.55436291033905,0.977109448317944
455,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,11,Up,0.555109428354483,0.977109448317944
456,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,29,Down,0.555727549358747,0.977109448317944
457,WP_OSTEOPONTIN_SIGNALING,11,Down,0.555909130459876,0.977109448317944
458,WP_GPCRS_CLASS_B_SECRETINLIKE,4,Up,0.556534745673291,0.977109448317944
459,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,41,Up,0.556676984443066,0.977109448317944
460,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,11,Up,0.557503815357868,0.977109448317944
461,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,30,Up,0.557802195513852,0.977109448317944
462,WP_TCELL_RECEPTOR_SIGNALING,71,Down,0.559086042355267,0.977109448317944
463,WP_NAD_BIOSYNTHETIC_PATHWAYS,19,Down,0.561867327252661,0.977109448317944
464,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,165,Up,0.567457779006433,0.977109448317944
465,WP_AGERAGE_PATHWAY,53,Up,0.567642893299121,0.977109448317944
466,WP_7OXOC_AND_7BETAHC_PATHWAYS,17,Up,0.568135640173974,0.977109448317944
467,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,4,Up,0.568247440337003,0.977109448317944
468,WP_NANOMATERIAL_INDUCED_APOPTOSIS,18,Up,0.57137840296981,0.977109448317944
469,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,6,Down,0.573153794027201,0.977109448317944
470,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,4,Up,0.574908030055421,0.977109448317944
471,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,4,Up,0.57543088261471,0.977109448317944
472,WP_6Q16_COPY_NUMBER_VARIATION,5,Down,0.575731299693781,0.977109448317944
473,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,29,Up,0.576510791123517,0.977109448317944
474,WP_CANNABINOID_RECEPTOR_SIGNALING,16,Down,0.576513045684008,0.977109448317944
475,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,32,Down,0.577310818545442,0.977109448317944
476,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,62,Up,0.58132962205544,0.977109448317944
477,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,7,Down,0.583762308025128,0.977109448317944
478,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,11,Up,0.584325066061068,0.977109448317944
479,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,11,Up,0.584951389212446,0.977109448317944
480,WP_INTEGRINMEDIATED_CELL_ADHESION,72,Down,0.585772380988316,0.977109448317944
481,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,24,Up,0.586526609853236,0.977109448317944
482,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,5,Up,0.586623905421165,0.977109448317944
483,WP_16P112_PROXIMAL_DELETION_SYNDROME,62,Down,0.588532754409452,0.977109448317944
484,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,83,Down,0.589433953194256,0.977109448317944
485,WP_NETRINUNC5B_SIGNALING,34,Up,0.589944662279626,0.977109448317944
486,WP_HEDGEHOG_SIGNALING_WP4249,24,Down,0.590836904748935,0.977109448317944
487,WP_RAS_SIGNALING,114,Up,0.590844271766026,0.977109448317944
488,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,48,Down,0.593155379475415,0.977109448317944
489,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,3,Up,0.595070475928958,0.977109448317944
490,WP_IL6_SIGNALING,38,Up,0.595081506031806,0.977109448317944
491,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,2,Down,0.59665879524931,0.977109448317944
492,WP_IL17_SIGNALING,25,Up,0.603622283107618,0.977109448317944
493,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,69,Down,0.605048685601276,0.977109448317944
494,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,23,Down,0.606730003402365,0.977109448317944
495,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,22,Up,0.612582229089517,0.977109448317944
496,WP_METABOLIC_EPILEPTIC_DISORDERS,57,Down,0.613689045997408,0.977109448317944
497,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,72,Up,0.614154619428291,0.977109448317944
498,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,32,Down,0.615729538224384,0.977109448317944
499,WP_OVARIAN_INFERTILITY,20,Up,0.618545837644485,0.977109448317944
500,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,76,Up,0.621661575128417,0.977109448317944
501,WP_IL2_SIGNALING,37,Up,0.621772039502225,0.977109448317944
502,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,50,Up,0.622088526457219,0.977109448317944
503,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,52,Up,0.622619382911421,0.977109448317944
504,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,8,Up,0.622675307987115,0.977109448317944
505,WP_TRANSSULFURATION_PATHWAY,8,Up,0.627615878280162,0.977109448317944
506,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,5,Down,0.627879323855215,0.977109448317944
507,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,35,Down,0.629702418235397,0.977109448317944
508,WP_TRANSLATION_FACTORS,49,Down,0.630209505132059,0.977109448317944
509,WP_ADIPOGENESIS,86,Up,0.630694405182583,0.977109448317944
510,WP_INCLUSION_BODY_MYOSITIS,9,Up,0.63089704152521,0.977109448317944
511,WP_DOPAMINERGIC_NEUROGENESIS,4,Down,0.634119444264141,0.977109448317944
512,WP_UREA_CYCLE_AND_RELATED_DISEASES,3,Up,0.634285112423393,0.977109448317944
513,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,12,Down,0.634449596572433,0.977109448317944
514,WP_PURINE_METABOLISM,10,Up,0.63466420283033,0.977109448317944
515,WP_MITOCHONDRIAL_BETAOXIDATION,8,Down,0.63488902417593,0.977109448317944
516,WP_WHITE_FAT_CELL_DIFFERENTIATION,23,Up,0.638656745996227,0.977109448317944
517,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,51,Down,0.638807752887284,0.977109448317944
518,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,16,Down,0.638985195454908,0.977109448317944
519,WP_ATM_SIGNALING,34,Up,0.639017983190483,0.977109448317944
520,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,8,Down,0.639840978420165,0.977109448317944
521,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,16,Down,0.641144834233989,0.977109448317944
522,WP_HIPPO_SIGNALING_REGULATION,43,Down,0.641831941634935,0.977109448317944
523,WP_TRYPTOPHAN_METABOLISM,18,Down,0.642800836818751,0.977109448317944
524,WP_16P112_DISTAL_DELETION_SYNDROME,20,Up,0.64299675252869,0.977109448317944
525,WP_MRNA_PROCESSING,124,Down,0.643971101440995,0.977109448317944
526,WP_IRINOTECAN_PATHWAY,5,Up,0.643981312085652,0.977109448317944
527,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,10,Up,0.643982592347778,0.977109448317944
528,WP_BDNFTRKB_SIGNALING,26,Up,0.644107866837326,0.977109448317944
529,WP_GALANIN_RECEPTOR_PATHWAY,10,Up,0.645255808723947,0.977109448317944
530,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,10,Up,0.649309350130319,0.977109448317944
531,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,46,Down,0.650921784035233,0.977109448317944
532,WP_AFLATOXIN_B1_METABOLISM,2,Up,0.652561886455732,0.977109448317944
533,WP_TARGET_OF_RAPAMYCIN_SIGNALING,32,Up,0.653410377491843,0.977109448317944
534,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,46,Up,0.654096016620141,0.977109448317944
535,WP_KCNQ2RELATED_EPILEPSIES,11,Down,0.654735049022032,0.977109448317944
536,WP_NEUROINFLAMMATION,10,Up,0.657766056417929,0.977109448317944
537,WP_DRAVET_SYNDROME,13,Up,0.659140431455306,0.977109448317944
538,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,23,Down,0.660762805781186,0.977109448317944
539,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,4,Up,0.661239616392641,0.977109448317944
540,WP_CORI_CYCLE,11,Up,0.661413161473393,0.977109448317944
541,WP_OSTEOBLAST_SIGNALING,3,Down,0.661715213330615,0.977109448317944
542,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,3,Up,0.662153206532983,0.977109448317944
543,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,37,Up,0.662953874469174,0.977109448317944
544,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,38,Down,0.665434782668313,0.977109448317944
545,WP_HYPERTROPHY_MODEL,13,Down,0.668429517946318,0.977109448317944
546,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,30,Up,0.669135355286409,0.977109448317944
547,WP_CILIOPATHIES,127,Down,0.669499733822995,0.977109448317944
548,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,19,Up,0.67104573985196,0.977109448317944
549,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1,Up,0.675306872077175,0.977109448317944
550,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,60,Up,0.675528171762382,0.977109448317944
551,WP_AXON_GUIDANCE,37,Up,0.675552355984158,0.977109448317944
552,WP_NUCLEOTIDE_EXCISION_REPAIR,43,Down,0.676429699667271,0.977109448317944
553,WP_REGULATION_OF_ACTIN_CYTOSKELETON,92,Down,0.679366885036553,0.977109448317944
554,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,30,Up,0.680288443031286,0.977109448317944
555,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,46,Down,0.682111802592263,0.977109448317944
556,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,12,Down,0.685813685255477,0.977109448317944
557,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,34,Down,0.685881372071233,0.977109448317944
558,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,27,Down,0.686842006559802,0.977109448317944
559,WP_TCELL_ACTIVATION_SARSCOV2,60,Up,0.68692412683057,0.977109448317944
560,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,9,Up,0.690105070751979,0.977109448317944
561,WP_FLUOROACETIC_ACID_TOXICITY,6,Down,0.691938444180711,0.977109448317944
562,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,31,Down,0.693031315162705,0.977109448317944
563,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,89,Down,0.695656388348423,0.977109448317944
564,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,14,Down,0.696566026243455,0.977109448317944
565,WP_PRIMARY_OVARIAN_INSUFFICIENCY,86,Down,0.697600154639936,0.977109448317944
566,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,11,Down,0.697866047367206,0.977109448317944
567,WP_NPHP1_DELETION_SYNDROME,10,Down,0.698243977967963,0.977109448317944
568,WP_GPR40_PATHWAY,7,Up,0.698323693171408,0.977109448317944
569,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,12,Up,0.699433401054105,0.977109448317944
570,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,56,Up,0.700549006759918,0.977109448317944
571,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,17,Down,0.701795512712605,0.977109448317944
572,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,12,Down,0.702613136183437,0.977109448317944
573,WP_RAC1PAK1P38MMP2_PATHWAY,51,Up,0.702787537754953,0.977109448317944
574,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,7,Up,0.705044386558327,0.977109448317944
575,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,47,Up,0.705509368004931,0.977109448317944
576,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,60,Up,0.710415837968008,0.977109448317944
577,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,23,Up,0.710484628539024,0.977109448317944
578,WP_ALANINE_AND_ASPARTATE_METABOLISM,5,Down,0.710943350677002,0.977109448317944
579,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,8,Down,0.712926846887402,0.977109448317944
580,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,30,Down,0.71297379420588,0.977109448317944
581,WP_SEROTONIN_TRANSPORTER_ACTIVITY,4,Down,0.713661757903763,0.977109448317944
582,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,13,Up,0.715417106602155,0.977109448317944
583,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,16,Up,0.716479056922441,0.977109448317944
584,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,3,Down,0.716636740660779,0.977109448317944
585,WP_VITAMIN_A1_AND_A5X_PATHWAYS,3,Down,0.718366059257626,0.977109448317944
586,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,18,Down,0.71946380110178,0.977109448317944
587,WP_5Q35_COPY_NUMBER_VARIATION,76,Up,0.720353652044696,0.977109448317944
588,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,22,Down,0.720379865954829,0.977109448317944
589,WP_MATRIX_METALLOPROTEINASES,8,Up,0.722687616819273,0.977109448317944
590,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,6,Up,0.722952017910112,0.977109448317944
591,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,6,Up,0.722952017910112,0.977109448317944
592,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,18,Down,0.723301211967153,0.977109448317944
593,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,79,Up,0.725038643354919,0.977109448317944
594,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,271,Up,0.725229763176379,0.977109448317944
595,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,13,Up,0.725731342943333,0.977109448317944
596,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,3,Down,0.727671243141376,0.977109448317944
597,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,54,Down,0.730242247066414,0.977109448317944
598,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,7,Down,0.731138689058952,0.977109448317944
599,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,15,Down,0.73141503321792,0.977109448317944
600,WP_DNA_REPLICATION,35,Up,0.732842440706084,0.977109448317944
601,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,9,Up,0.738169006189937,0.977109448317944
602,WP_MAPK_CASCADE,30,Down,0.738607535709054,0.977109448317944
603,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,28,Down,0.738708280413893,0.977109448317944
604,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,16,Up,0.739060669460478,0.977109448317944
605,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,7,Up,0.740043204627922,0.977109448317944
606,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,21,Up,0.74029811784135,0.977109448317944
607,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,34,Up,0.741526716230937,0.977109448317944
608,WP_CILIARY_LANDSCAPE,184,Up,0.741800223824521,0.977109448317944
609,WP_MAPK_SIGNALING,162,Up,0.743507514051997,0.977109448317944
610,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,43,Down,0.743578227574185,0.977109448317944
611,WP_OXIDATION_BY_CYTOCHROME_P450,14,Down,0.744195997979206,0.977109448317944
612,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,4,Down,0.748211663154993,0.977109448317944
613,WP_INTERFERON_TYPE_I_SIGNALING,50,Down,0.748504865706333,0.977109448317944
614,WP_COVID19_STRUCTURAL_COVERAGE_MAP,19,Down,0.748551025667592,0.977109448317944
615,WP_IL4_SIGNALING,50,Down,0.750362859792278,0.977109448317944
616,WP_NOTCH_SIGNALING_WP268,35,Up,0.751401045948158,0.977109448317944
617,WP_EFFECTS_OF_MFN2_MUTATION,17,Up,0.751679063314605,0.977109448317944
618,WP_AEROBIC_GLYCOLYSIS,10,Up,0.752150765304682,0.977109448317944
619,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,10,Up,0.752150765304682,0.977109448317944
620,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,5,Down,0.753819646644157,0.977109448317944
621,WP_ESTROGEN_METABOLISM_WP5276,8,Up,0.753924961479201,0.977109448317944
622,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,85,Up,0.754296811832202,0.977109448317944
623,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1,Up,0.75445807195223,0.977109448317944
624,WP_PREGNANE_X_RECEPTOR_PATHWAY,13,Up,0.755138270058036,0.977109448317944
625,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,20,Down,0.755699122360681,0.977109448317944
626,WP_UNFOLDED_PROTEIN_RESPONSE,24,Down,0.756362404482456,0.977109448317944
627,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,11,Down,0.757634445243464,0.977109448317944
628,WP_MONOAMINE_TRANSPORT,12,Down,0.75936196582551,0.977109448317944
629,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.760018123721191,0.977109448317944
630,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,19,Up,0.761000616242995,0.977109448317944
631,WP_PENTOSE_PHOSPHATE_METABOLISM,7,Down,0.761144285026328,0.977109448317944
632,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,47,Down,0.761556323262742,0.977109448317944
633,WP_B_CELL_RECEPTOR_SIGNALING,83,Down,0.761593625115857,0.977109448317944
634,WP_LEPTIN_AND_ADIPONECTIN,8,Up,0.76192772249799,0.977109448317944
635,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,65,Up,0.761961243565161,0.977109448317944
636,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,43,Up,0.765192807442365,0.977109448317944
637,WP_HISTONE_MODIFICATIONS,37,Up,0.770569218215982,0.977109448317944
638,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,25,Down,0.771214656624269,0.977109448317944
639,WP_ONCOSTATIN_M_SIGNALING,53,Up,0.771749323677019,0.977109448317944
640,WP_NONHOMOLOGOUS_END_JOINING,10,Down,0.772077025559099,0.977109448317944
641,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,40,Up,0.772547137076504,0.977109448317944
642,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,6,Up,0.773760445552444,0.977109448317944
643,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,19,Up,0.776488870151235,0.977109448317944
644,WP_THIAMINE_METABOLIC_PATHWAYS,9,Down,0.777711597572383,0.977109448317944
645,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,88,Up,0.777767857325291,0.977109448317944
646,WP_TGFBETA_RECEPTOR_SIGNALING,35,Down,0.778716589195531,0.977109448317944
647,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,2,Up,0.779471358854046,0.977109448317944
648,WP_METHYLATION_PATHWAYS,5,Down,0.781100639887344,0.977109448317944
649,WP_INSULIN_SIGNALING,128,Down,0.781314882877465,0.977109448317944
650,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,16,Down,0.781985359296773,0.977109448317944
651,WP_SARSCOV2_AND_COVID19_PATHWAY,6,Down,0.782960550084728,0.977109448317944
652,WP_G_PROTEIN_SIGNALING,61,Down,0.784082443723228,0.977109448317944
653,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,125,Up,0.784628141342206,0.977109448317944
654,WP_MIRNA_BIOGENESIS,6,Down,0.784637924572652,0.977109448317944
655,WP_TNFALPHA_SIGNALING,82,Down,0.785358637144235,0.977109448317944
656,WP_ALPHA_6_BETA_4_SIGNALING,25,Up,0.785616894278395,0.977109448317944
657,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,3,Down,0.786289512433035,0.977109448317944
658,WP_NRXN1_DELETION_SYNDROME,2,Up,0.787236724251921,0.977109448317944
659,WP_ENDOTHELIN_PATHWAYS,12,Up,0.790632621731461,0.977109448317944
660,WP_SLEEP_REGULATION,11,Up,0.790640023885791,0.977109448317944
661,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,21,Up,0.790691943130791,0.977109448317944
662,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,12,Up,0.790700766710631,0.977109448317944
663,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,5,Down,0.794050661514663,0.977109448317944
664,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,18,Up,0.795797922741372,0.977109448317944
665,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,17,Down,0.796122579244353,0.977109448317944
666,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,15,Up,0.797187974744842,0.977109448317944
667,WP_COMPLEMENT_SYSTEM,49,Up,0.797252219018378,0.977109448317944
668,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,32,Down,0.797385787213409,0.977109448317944
669,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,7,Down,0.798129327447018,0.977109448317944
670,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,3,Down,0.798901006420017,0.977109448317944
671,WP_OREXIN_RECEPTOR_PATHWAY,116,Down,0.799251998966893,0.977109448317944
672,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,27,Down,0.799543915683346,0.977109448317944
673,WP_FATTY_ACID_OMEGAOXIDATION,2,Up,0.80008098014344,0.977109448317944
674,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,13,Down,0.801182199715687,0.977109448317944
675,WP_ACE_INHIBITOR_PATHWAY,5,Down,0.804985586467513,0.979233605969589
676,WP_ACUTE_MYELOID_LEUKEMIA,55,Up,0.808316075701705,0.979233605969589
677,WP_GLYCOLYSIS_IN_SENESCENCE,11,Up,0.809329290831354,0.979233605969589
678,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,41,Down,0.809650377939294,0.979233605969589
679,WP_SERINE_METABOLISM,5,Up,0.811559941718217,0.979233605969589
680,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,13,Down,0.811960322165554,0.979233605969589
681,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,9,Down,0.812454159697396,0.979233605969589
682,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,9,Down,0.812454159697396,0.979233605969589
683,WP_LIPID_PARTICLES_COMPOSITION,5,Up,0.813969260868937,0.979623327136554
684,WP_FATTY_ACID_BIOSYNTHESIS,21,Up,0.817842795762736,0.982588862249657
685,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,39,Up,0.818824051874714,0.982588862249657
686,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,54,Down,0.820455775857934,0.983111731421606
687,WP_CAMKK2_PATHWAY,29,Up,0.822438758801115,0.983249896883524
688,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,4,Up,0.823082592140156,0.983249896883524
689,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,8,Down,0.824159585100667,0.983249896883524
690,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,15,Up,0.826119189749962,0.984159382571694
691,WP_FATTY_ACID_BETAOXIDATION,29,Down,0.829099792055504,0.985190474817857
692,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,10,Down,0.829381762255422,0.985190474817857
693,WP_MELATONIN_METABOLISM_AND_EFFECTS,19,Up,0.832534389090905,0.987508322990943
694,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,16,Up,0.835509573302755,0.989609321692888
695,WP_SEROTONIN_AND_ANXIETY,6,Up,0.838316026441981,0.991504710410516
696,WP_TYPE_II_DIABETES_MELLITUS,14,Down,0.843739371104455,0.993916556565231
697,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,7,Up,0.845169170616889,0.993916556565231
698,WP_TYPE_III_INTERFERON_SIGNALING,7,Down,0.845740380883199,0.993916556565231
699,WP_OMEGA9_FATTY_ACID_SYNTHESIS,11,Down,0.846951653568121,0.993916556565231
700,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,7,Up,0.848102485870171,0.993916556565231
701,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,4,Down,0.848708348515765,0.993916556565231
702,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,2,Down,0.85013975247579,0.993916556565231
703,WP_IL1_SIGNALING,51,Down,0.85210537308687,0.993916556565231
704,WP_GASTRIN_SIGNALING,92,Down,0.852316743788708,0.993916556565231
705,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,8,Up,0.852446681725654,0.993916556565231
706,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,15,Up,0.856548870827172,0.994842560280766
707,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,25,Up,0.857911620360875,0.994842560280766
708,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,23,Down,0.862112686605791,0.994842560280766
709,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,5,Up,0.863643999861564,0.994842560280766
710,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,23,Up,0.864876018590197,0.994842560280766
711,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,15,Down,0.867117270951041,0.994842560280766
712,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,14,Down,0.867181766672948,0.994842560280766
713,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,10,Up,0.867671277368311,0.994842560280766
714,WP_ANDROGEN_RECEPTOR_SIGNALING,77,Down,0.86902723579443,0.994842560280766
715,WP_DNA_MISMATCH_REPAIR,21,Down,0.870640632414509,0.994842560280766
716,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,12,Up,0.873571565686599,0.994842560280766
717,WP_KIT_RECEPTOR_SIGNALING,49,Down,0.874169965445073,0.994842560280766
718,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,21,Down,0.876684261864325,0.994842560280766
719,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,8,Up,0.878533161587757,0.994842560280766
720,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,21,Down,0.878846472336809,0.994842560280766
721,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,5,Down,0.879717816311079,0.994842560280766
722,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,5,Up,0.880182986438533,0.994842560280766
723,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,12,Down,0.881888546597822,0.994842560280766
724,WP_LUNG_PATHOLOGY_OF_COVID19,13,Down,0.882077271203038,0.994842560280766
725,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,4,Up,0.882261216166716,0.994842560280766
726,WP_LIPID_METABOLISM_PATHWAY,23,Down,0.882795655710057,0.994842560280766
727,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,9,Up,0.885886767088518,0.994842560280766
728,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,14,Down,0.887207276691139,0.994842560280766
729,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,37,Down,0.891077150036549,0.994842560280766
730,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,63,Down,0.892007522427292,0.994842560280766
731,WP_VEGFAVEGFR2_SIGNALING,334,Down,0.89443982630408,0.994842560280766
732,WP_BLADDER_CANCER,29,Up,0.896038616122795,0.994842560280766
733,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,55,Up,0.896349179200604,0.994842560280766
734,WP_RIBOFLAVIN_AND_COQ_DISORDERS,13,Down,0.89848108208101,0.994842560280766
735,WP_MICROTUBULE_CYTOSKELETON_REGULATION,35,Down,0.899599060631898,0.994842560280766
736,WP_HEPATITIS_B_INFECTION,115,Up,0.900017586246522,0.994842560280766
737,WP_CHOLESTEROL_METABOLISM,53,Down,0.901254041703494,0.994842560280766
738,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,3,Up,0.902330373770284,0.994842560280766
739,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,9,Up,0.903171374730527,0.994842560280766
740,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,10,Down,0.903936621284754,0.994842560280766
741,WP_LEPTIN_SIGNALING,69,Down,0.905825650589464,0.994842560280766
742,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,23,Up,0.906870594988917,0.994842560280766
743,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,26,Up,0.906900430065817,0.994842560280766
744,WP_KLEEFSTRA_SYNDROME,25,Down,0.907340032940966,0.994842560280766
745,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,37,Up,0.90737081838373,0.994842560280766
746,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,7,Up,0.911336017851353,0.994842560280766
747,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,12,Up,0.91207774880595,0.994842560280766
748,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,4,Down,0.914329805040609,0.994842560280766
749,WP_CALORIC_RESTRICTION_AND_AGING,7,Up,0.915057753680281,0.994842560280766
750,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,21,Up,0.915063210790585,0.994842560280766
751,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,24,Up,0.918711815152063,0.994842560280766
752,WP_APOPTOSIS_MODULATION_BY_HSP70,17,Up,0.920858029409456,0.994842560280766
753,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,27,Down,0.921259915483039,0.994842560280766
754,WP_MACROPHAGE_MARKERS,8,Down,0.922411539225327,0.994842560280766
755,WP_PHOSPHOINOSITIDES_METABOLISM,38,Up,0.92294759598567,0.994842560280766
756,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,21,Down,0.92371554671148,0.994842560280766
757,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,18,Up,0.92382587571502,0.994842560280766
758,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,16,Down,0.924495525062221,0.994842560280766
759,WP_KETOGENESIS_AND_KETOLYSIS,6,Up,0.926297751570628,0.994842560280766
760,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,57,Up,0.927000137484416,0.994842560280766
761,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,4,Down,0.927840247817109,0.994842560280766
762,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,40,Down,0.928732949628537,0.994842560280766
763,WP_METASTATIC_BRAIN_TUMOR,5,Up,0.92954766591194,0.994842560280766
764,WP_BARDETBIEDL_SYNDROME,65,Down,0.930865440701785,0.994842560280766
765,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,21,Down,0.931440620548102,0.994842560280766
766,WP_CYTOSOLIC_DNASENSING_PATHWAY,53,Down,0.931497662566444,0.994842560280766
767,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,29,Down,0.931913723605662,0.994842560280766
768,WP_EGFEGFR_SIGNALING,136,Down,0.932279519626227,0.994842560280766
769,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,4,Down,0.932284733410906,0.994842560280766
770,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,20,Down,0.932884063067474,0.994842560280766
771,WP_ENDOCHONDRAL_OSSIFICATION,26,Down,0.936496629545888,0.994842560280766
772,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,26,Down,0.936496629545888,0.994842560280766
773,WP_WNT_SIGNALING_WP363,36,Down,0.936727533110878,0.994842560280766
774,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,4,Down,0.939442725064264,0.994842560280766
775,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,9,Up,0.93958427527641,0.994842560280766
776,WP_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.940380376323789,0.994842560280766
777,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,23,Up,0.940380376323789,0.994842560280766
778,WP_ACUTE_VIRAL_MYOCARDITIS,64,Down,0.941967452693655,0.995240676239312
779,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,3,Up,0.945483674508583,0.99693055385085
780,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,47,Up,0.945992496354822,0.99693055385085
781,WP_OPIOID_RECEPTOR_PATHWAYS,25,Up,0.949302855983454,0.996937622302639
782,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,17,Down,0.949460505763653,0.996937622302639
783,WP_TLR4_SIGNALING_AND_TOLERANCE,26,Down,0.949794384593492,0.996937622302639
784,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,46,Down,0.954296801704526,0.996937622302639
785,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,90,Up,0.954601706100112,0.996937622302639
786,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,42,Up,0.954788056553932,0.996937622302639
787,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,30,Up,0.955021582849544,0.996937622302639
788,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,62,Up,0.956092346739122,0.996937622302639
789,WP_ALZHEIMERS_DISEASE,183,Up,0.958422129605012,0.996937622302639
790,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,183,Up,0.958422129605012,0.996937622302639
791,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,16,Up,0.960653952485692,0.996937622302639
792,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,7,Down,0.962431895674154,0.996937622302639
793,WP_IL5_SIGNALING,37,Down,0.963119683581766,0.996937622302639
794,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,6,Up,0.964368479266652,0.996937622302639
795,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,7,Up,0.964787111870412,0.996937622302639
796,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,18,Down,0.966334372985996,0.996937622302639
797,WP_MEASLES_VIRUS_INFECTION,99,Up,0.96661713500633,0.996937622302639
798,WP_IL11_SIGNALING,40,Up,0.969510505679978,0.998039672931323
799,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,11,Down,0.971343143473276,0.998039672931323
800,WP_FOCAL_ADHESION,117,Down,0.972688410001305,0.998039672931323
801,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,24,Up,0.974456071172538,0.998039672931323
802,WP_STEROID_BIOSYNTHESIS,2,Down,0.975057765322135,0.998039672931323
803,WP_GLYOXYLATE_METABOLISM,5,Up,0.975997308771417,0.998039672931323
804,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,19,Up,0.981890967384547,0.998039672931323
805,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,19,Up,0.981907807360103,0.998039672931323
806,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,35,Up,0.983415481048601,0.998039672931323
807,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,13,Up,0.983958428662301,0.998039672931323
808,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,6,Up,0.984543053285676,0.998039672931323
809,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,26,Down,0.985710004489294,0.998039672931323
810,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,7,Down,0.985847708164484,0.998039672931323
811,WP_HEART_DEVELOPMENT,16,Up,0.988573718898028,0.998039672931323
812,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,19,Down,0.988907541493327,0.998039672931323
813,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,9,Up,0.989579477637347,0.998039672931323
814,WP_PARKINSONS_DISEASE_PATHWAY,26,Up,0.98996471129085,0.998039672931323
815,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,14,Up,0.99069826871222,0.998039672931323
816,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,11,Down,0.990754711815036,0.998039672931323
817,WP_VITAMIN_D_RECEPTOR_PATHWAY,81,Down,0.992443365263854,0.99851707006963
818,WP_SPINA_BIFIDA,10,Up,0.994872940535307,0.998776640810852
819,WP_ULCERATIVE_COLITIS_SIGNALING,12,Down,0.995131470588914,0.998776640810852
820,WP_AMINO_ACID_METABOLISM,59,Up,0.996871398435091,0.999102584386401
821,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,18,Up,0.997970996394617,0.999102584386401
822,WP_TCA_CYCLE_IN_SENESCENCE,10,Down,0.999102584386401,0.999102584386401
